HK1093060A1 - 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs - Google Patents
4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogsInfo
- Publication number
- HK1093060A1 HK1093060A1 HK06113838.3A HK06113838A HK1093060A1 HK 1093060 A1 HK1093060 A1 HK 1093060A1 HK 06113838 A HK06113838 A HK 06113838A HK 1093060 A1 HK1093060 A1 HK 1093060A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- phenoxyalkyl
- phenoxyacetic
- aci
- thio
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50408903P | 2003-09-19 | 2003-09-19 | |
PCT/US2004/030188 WO2005030694A1 (en) | 2003-09-19 | 2004-09-16 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1093060A1 true HK1093060A1 (en) | 2007-02-23 |
Family
ID=34392924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06113838.3A HK1093060A1 (en) | 2003-09-19 | 2006-12-15 | 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs |
Country Status (31)
Country | Link |
---|---|
US (4) | US7598292B2 (pl) |
EP (2) | EP2243766B1 (pl) |
JP (1) | JP5016922B2 (pl) |
KR (1) | KR101094742B1 (pl) |
CN (1) | CN1882524B (pl) |
AR (1) | AR045774A1 (pl) |
AT (1) | ATE476408T1 (pl) |
AU (1) | AU2004276231B2 (pl) |
BR (1) | BRPI0414534B8 (pl) |
CA (1) | CA2539403C (pl) |
CO (1) | CO5680473A2 (pl) |
CR (1) | CR8303A (pl) |
CY (2) | CY1110847T1 (pl) |
DE (1) | DE602004028500D1 (pl) |
DK (2) | DK2243766T3 (pl) |
EA (1) | EA009119B1 (pl) |
EC (1) | ECSP066435A (pl) |
ES (2) | ES2555031T3 (pl) |
HK (1) | HK1093060A1 (pl) |
HU (1) | HUE028213T2 (pl) |
IL (1) | IL174399A (pl) |
NO (1) | NO337041B1 (pl) |
NZ (1) | NZ545971A (pl) |
PL (2) | PL2243766T3 (pl) |
PT (2) | PT1670744E (pl) |
SG (1) | SG149041A1 (pl) |
SI (2) | SI2243766T1 (pl) |
TW (1) | TWI330630B (pl) |
UA (1) | UA87468C2 (pl) |
WO (1) | WO2005030694A1 (pl) |
ZA (1) | ZA200603084B (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004285849B2 (en) * | 2003-09-19 | 2011-04-28 | Janssen Pharmaceutica, N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
MY145712A (en) * | 2004-09-15 | 2012-03-30 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
MY147518A (en) * | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
UY30288A1 (es) | 2006-04-18 | 2007-08-31 | Janssen Pharmaceutica Nv | Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol |
US20130197043A1 (en) | 2010-08-31 | 2013-08-01 | Snu R&Db Foundation | Use of the fetal reprogramming of a ppar agonist |
CN103183612A (zh) * | 2011-12-30 | 2013-07-03 | 北大方正集团有限公司 | 二丙基丙二酸二酯的制备方法 |
IN2014MN01547A (pl) | 2012-02-10 | 2015-05-08 | Lupin Ltd | |
CN106188097B (zh) * | 2016-07-08 | 2018-01-05 | 郑州大学 | 一种3‑氯甲基氧头孢烯类抗生素母核的制备方法 |
JP7065839B2 (ja) * | 2016-10-05 | 2022-05-12 | ミトブリッジ,インコーポレーテッド | 急性腎障害を処置する方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4125732A (en) * | 1977-05-06 | 1978-11-14 | American Cyanamid Company | 2-Aryloxy-2-(phenoxyalkoxy)phenyl acetic acid and esters |
EP0056172B1 (en) | 1981-01-09 | 1985-04-03 | FISONS plc | Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them |
JPS58177934A (ja) | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
DE3366107D1 (en) * | 1982-09-30 | 1986-10-16 | Merck Frosst Canada Inc | Leukotriene antagonists, their production, and compositions containing them |
US4820867A (en) * | 1983-04-21 | 1989-04-11 | Merck Frosst Canada, Inc. | Phenoxypropoxy halophenylacetic acids as leukotriene antagonists |
JPS61268651A (ja) * | 1985-05-23 | 1986-11-28 | Takeda Chem Ind Ltd | フエニル酢酸誘導体およびその製造法 |
US5726165A (en) * | 1994-07-29 | 1998-03-10 | Smithkline Beecham P.L.C. | Derivatives of 4-(2-aminoethyl)phenoxymethyl-phosphonic and -phosphinic acid and pharmaceutical and veterinary uses therefor |
WO1997027847A1 (en) * | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
EP1040102B1 (en) * | 1997-12-19 | 2007-01-24 | Merck & Co., Inc. | Arylthiazolidinedione derivatives |
EP1194146B1 (en) * | 1999-06-18 | 2006-07-19 | Merck & Co., Inc. | Arylthiazolidinedione and aryloxazolidinedione derivatives |
GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
GB0003310D0 (en) * | 2000-02-15 | 2000-04-05 | Univ Sheffield | Bone formation |
BR0211414A (pt) | 2001-07-30 | 2004-08-17 | Novo Nordisk As | Composto, uso do mesmo, composição farmacêutica, e, métodos para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e de diabetes tipo i, diabetes tipo ii, tolerância à glicose, resistência à insulina ou obesidade prejudicadas |
AU2003224632A1 (en) * | 2002-03-01 | 2003-09-16 | Smithkline Beecham Corporation | Hppars activators |
EP1660428A1 (en) * | 2003-08-20 | 2006-05-31 | Eli Lilly And Company | Ppar modulators |
AU2004285849B2 (en) * | 2003-09-19 | 2011-04-28 | Janssen Pharmaceutica, N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
MY145712A (en) | 2004-09-15 | 2012-03-30 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
MY147518A (en) | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
JO3006B1 (ar) * | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
-
2004
- 2004-09-16 ES ES10008042.3T patent/ES2555031T3/es not_active Expired - Lifetime
- 2004-09-16 CA CA2539403A patent/CA2539403C/en not_active Expired - Lifetime
- 2004-09-16 DK DK10008042.3T patent/DK2243766T3/en active
- 2004-09-16 US US10/942,563 patent/US7598292B2/en active Active
- 2004-09-16 ES ES04784146T patent/ES2349143T3/es not_active Expired - Lifetime
- 2004-09-16 PL PL10008042T patent/PL2243766T3/pl unknown
- 2004-09-16 DK DK04784146.5T patent/DK1670744T5/da active
- 2004-09-16 UA UAA200603108A patent/UA87468C2/ru unknown
- 2004-09-16 SI SI200432276T patent/SI2243766T1/sl unknown
- 2004-09-16 AU AU2004276231A patent/AU2004276231B2/en not_active Expired
- 2004-09-16 SG SG200809395-7A patent/SG149041A1/en unknown
- 2004-09-16 CN CN2004800337382A patent/CN1882524B/zh not_active Expired - Lifetime
- 2004-09-16 BR BRPI0414534A patent/BRPI0414534B8/pt active IP Right Grant
- 2004-09-16 JP JP2006526992A patent/JP5016922B2/ja not_active Expired - Lifetime
- 2004-09-16 DE DE602004028500T patent/DE602004028500D1/de not_active Expired - Lifetime
- 2004-09-16 PT PT04784146T patent/PT1670744E/pt unknown
- 2004-09-16 KR KR1020067007361A patent/KR101094742B1/ko active IP Right Grant
- 2004-09-16 PL PL04784146T patent/PL1670744T3/pl unknown
- 2004-09-16 PT PT100080423T patent/PT2243766E/pt unknown
- 2004-09-16 EP EP10008042.3A patent/EP2243766B1/en not_active Expired - Lifetime
- 2004-09-16 AT AT04784146T patent/ATE476408T1/de active
- 2004-09-16 EP EP04784146A patent/EP1670744B9/en not_active Expired - Lifetime
- 2004-09-16 EA EA200600439A patent/EA009119B1/ru unknown
- 2004-09-16 NZ NZ545971A patent/NZ545971A/en unknown
- 2004-09-16 HU HUE10008042A patent/HUE028213T2/en unknown
- 2004-09-16 WO PCT/US2004/030188 patent/WO2005030694A1/en active Application Filing
- 2004-09-16 SI SI200431520T patent/SI1670744T1/sl unknown
- 2004-09-17 TW TW093127865A patent/TWI330630B/zh active
- 2004-09-20 AR ARP040103377A patent/AR045774A1/es active IP Right Grant
-
2006
- 2006-03-17 EC EC2006006435A patent/ECSP066435A/es unknown
- 2006-03-19 IL IL174399A patent/IL174399A/en active IP Right Grant
- 2006-03-20 CR CR8303A patent/CR8303A/es unknown
- 2006-03-30 CO CO06031467A patent/CO5680473A2/es active IP Right Grant
- 2006-04-18 ZA ZA200603084A patent/ZA200603084B/en unknown
- 2006-04-19 NO NO20061711A patent/NO337041B1/no unknown
- 2006-12-15 HK HK06113838.3A patent/HK1093060A1/xx unknown
-
2009
- 2009-08-28 US US12/549,431 patent/US8008513B2/en not_active Expired - Lifetime
-
2010
- 2010-10-18 CY CY20101100933T patent/CY1110847T1/el unknown
-
2011
- 2011-08-11 US US13/207,809 patent/US8258177B2/en not_active Expired - Lifetime
-
2012
- 2012-08-29 US US13/597,316 patent/US8450371B2/en not_active Expired - Lifetime
-
2015
- 2015-11-06 CY CY20151100994T patent/CY1117666T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL174398A0 (en) | 4-((phenoxyalkyl) thio)-phenoxyacetic acids and analogs | |
HK1093060A1 (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs | |
HK1101758A1 (zh) | 苯氧基烷基 硫基 -苯氧基乙酸及類似物 | |
EG23825A (en) | Bandwidth adaptation | |
EP1575650A4 (en) | BUCCAL TIP | |
IL173522A0 (en) | Phenoxyacetic acid derivatives | |
AU2003251088A8 (en) | Nasal devices | |
GB0307213D0 (en) | Nasal devices | |
GB0209494D0 (en) | Nasal devices | |
GB0207817D0 (en) | Nasal devices | |
HK1104523A1 (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs 4-(())- | |
AU2003216418A8 (en) | Skateboards | |
PT2494962E (pt) | Administração pulmonar de levodopa | |
AU2002319899A1 (en) | Novel resveratrol analogs | |
AU2003298238A8 (en) | Managing data consistency | |
GB0214031D0 (en) | Skate | |
AP2005003329A0 (en) | Chemically acidified formula | |
EP1529495A4 (en) | RESECTOSCOPE | |
EP1571895A4 (en) | COIL | |
AU2003210864A8 (en) | Thirty-degree length impedance transformer | |
EP1407718A4 (en) | resectoscope | |
AU153474S (en) | Mouthpiece | |
TW542155U (en) | Dragging structure for skateboard | |
EG26303A (en) | Eye drops containing mercury chloride | |
TW582260U (en) | Dual-dispensing type tissue box |